These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1011867)

  • 1. Studies on the mechanism of antitumour activity of Ledakrin.
    Konopa J; Chotkowska E; Koldej K; Matuszkiewicz A; Pawlak JW; Woynarowski JM
    Mater Med Pol; 1976; 8(3):258-65. PubMed ID: 1011867
    [No Abstract]   [Full Text] [Related]  

  • 2. Antineoplastic activity of C-283 preparation (Ledakrin) in model experiments.
    Radzikowski C
    Mater Med Pol; 1976; 8(3):345-9. PubMed ID: 1034860
    [No Abstract]   [Full Text] [Related]  

  • 3. The mechanism of inhibition of DNA transcription in vitro by nitracrine (Ledakrin, C-283).
    Slaska K; Szmigiero L; Jaros-Kamińska B; Ciesielska E; Gniazdowski M
    Mol Pharmacol; 1979 Jul; 16(1):287-96. PubMed ID: 384208
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of Ledakrin on renal and hepatic functions.
    Bratkowska-Seniów B; Kaniak T; Stumpf A; Wahl-Mugeńska M; Wojnarska J
    Mater Med Pol; 1976; 8(3):316-22. PubMed ID: 1011874
    [No Abstract]   [Full Text] [Related]  

  • 5. Morphologic blood pattern in patients treated with Ledakrin.
    Bratkowska-Seniów B; Dziedzic J; Fengler I; Steuden W; Szymaniec S; Wysocka M
    Mater Med Pol; 1976; 8(3):295-301. PubMed ID: 1011872
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of 1-nitro-9-aminoalkylacridine (Ledakrin, C-283) binding with chromatin on DNA template activity (preliminary report)].
    Wilmańska D; Szmigiero L; Malagocka S; Jaros-Kamińska B; Gniazdowski M
    Med Dosw Mikrobiol; 1977; 29(2):147-52. PubMed ID: 330983
    [No Abstract]   [Full Text] [Related]  

  • 7. Ledakrin--anticancerous medicine 1-nitro-9(3-dimethylaminopropylamino)-acridine -2HCl-H2O.
    Ledochowski A
    Mater Med Pol; 1976; 8(3):237-51. PubMed ID: 796591
    [No Abstract]   [Full Text] [Related]  

  • 8. Excretion and organ distribution of the cytostatic preparation Ledakrin (preparation C-283) in rat.
    Jerzykowski T; Szalsza-Kuśnierczyk M; Chalupka G; Chorazy M
    Acta Med Pol; 1976; 17(3):169-74. PubMed ID: 998329
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.
    Lee HH; Wilson WR; Ferry DM; van Zijl P; Pullen SM; Denny WA
    J Med Chem; 1996 Jun; 39(13):2508-17. PubMed ID: 8691448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of inhibition of DNA-dependent RNA synthesis in vitro by Ledakrin.
    Gniazdowski M
    Mater Med Pol; 1978; 10(3):159-65. PubMed ID: 723289
    [No Abstract]   [Full Text] [Related]  

  • 11. The mode of action of cytotoxic and antitumor 1-nitroacridines. II. In vivo enzyme-mediated covalent binding of a 1-nitroacridine derivative, Ledakrin or Nitracrine, with dna and other macromolecules of mammalian or bacterial cells.
    Pawlak JW; Pawlak K; Konopa J
    Chem Biol Interact; 1983 Feb; 43(2):151-73. PubMed ID: 6402314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of pharmacological activity several acridine derivatives with cytostatic and oncostatic properties.
    Gieldanowski J
    Mater Med Pol; 1976; 8(3):252-7. PubMed ID: 1034858
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppressive activity of ledakrin.
    Giełdanowski J; Skowrońska J
    Arch Immunol Ther Exp (Warsz); 1979; 27(3):315-9. PubMed ID: 383038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A search for new antitumor compounds. Biological studies. 3. Antitumor properties of 14 new acridine derivatives.
    Radzikowski C; Ledóchowski Z; Ledóchowski A; Peryt J; Hrabowska M; Konopa J; Balk M; Jereczek E
    Arch Immunol Ther Exp (Warsz); 1967; 15(2):233-40. PubMed ID: 6050441
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure of acridines and their effect on RNA synthesis in vitro.
    Szmigiero L; Slaska K; Ciesielska E; Jaros-Kamińska B; Gniazdowski M
    Acta Biochim Pol; 1977; 24(1):35-44. PubMed ID: 868436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A search for new antitumor compounds. Biological studies. IV. Antitumor properties of 21 new acridine derivatives.
    Radzikowski C; Ledóchowski Z; Ledóchowski A; Bogucka M; Hrabowska M; Konopa J; Balk M; Jereczek E
    Arch Immunol Ther Exp (Warsz); 1967; 15(2):241-8. PubMed ID: 6050442
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bacteriostatic, antimycotic and antitrichomonal effects in vitro of a new antineoplastic drug, Ledakrin, Polfa].
    Kurnatowska A; Kadlubowski R
    Pol Tyg Lek; 1977 Nov; 32(45):1767-9. PubMed ID: 303764
    [No Abstract]   [Full Text] [Related]  

  • 18. 32P-post-labeling analysis of DNA adduct formation by antitumor drug nitracrine (Ledakrin) and other nitroacridines in different biological systems.
    Bartoszek A; Konopa J
    Biochem Pharmacol; 1989 Apr; 38(8):1301-12. PubMed ID: 2706021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on antitumor and myelotoxic effect of Ledakrin and its selected analogues.
    Glazman-Kuśnierczyk H; Radzikowski C; Budzyński W; Paprocka M
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):385-93. PubMed ID: 6191735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of antitumor properties of acridine derivatives on the basis of the results from some in vivo and in vitro tests.
    Radzikowski C; Ledóchowski Z; Ledóchowski A; Wrzolek S; Hrabowska M; Konopa J
    Arch Immunol Ther Exp (Warsz); 1967; 15(1):126-8. PubMed ID: 6048222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.